Built on Experience

For 25+ years, Medidata has redefined clinical development to accelerate smarter treatments and healthier lives—and continues to shape what comes next.

Powering Smarter Treatments and Healthier People

Medidata, a Dassault Systèmes’ brand and global leader in clinical trial solutions, has driven ground-breaking technological innovation across 38,000+ trials and 12 million patients, delivering industry-leading expertise, analytics-powered insights, and one of the largest clinical trial data sets in the industry.

Today, one million users across 2,300 organizations trust our seamless, end-to-end platform to improve patient experiences, accelerate clinical breakthroughs, and bring therapies to market faster.


Leadership

Tarek Sherif

  • Life Sciences & Healthcare Sector Board Chairman for Dassault Systèmes

Anthony Costello

  • Chief Executive Officer

Janet Butler

  • EVP, Head of Global Sales

Tom Doyle

  • SVP, Chief Technology Officer

Rick Goldstein

  • EVP, General Counsel

Lisa Moneymaker

  • SVP, Chief Strategy Officer

Edwin Ng

  • SVP, General Manager, Asia Pacific

Matt Noble

  • SVP, Head of Patient Experience

Jennifer Plumer

  • SVP, Head of Marketing

Joe Schmidt

  • Chief Operating Officer

Josh Schwartz

  • SVP, Chief Financial Officer

Esmerita Sepulveda-Lusky

  • SVP, Head of People

Alicia Staley

  • SVP, Chief Patient Officer

Our Story

Medidata was founded to drive smarter treatments and healthier lives. 



What followed is a 25+ year journey of milestones that reshaped clinical development—and continue to define what’s next.

Medidata Is Founded

Fund manager Tarek Sherif moves into a small office with tech entrepreneur and researcher Glen de Vries, who hand-codes Medidata’s original software. Together with Ed Ikeguchi, they found Medidata.

June 1999

EDC Launches

The first software to digitally collect clinical trial data. Later named Rave EDC (Electronic Data Capture), it transforms 
data capture to become the world’s most advanced, robust, and secure system for managing clinical trial site, patient, and lab data.

June 1999

Medidata Opens London Office

June 2004

Medidata Opens Tokyo Office

June 2005

Medidata NEXT Launches

A Rave best-practices forum, the Medidata User Group (MUG), becomes Medidata Symposium in 2015 and Medidata NEXT in 2017. Today, it convenes industry leaders and patient advocates 
to shape the future of life sciences.

2006

Initial Public Offering on NASDAQ

June 2009

Acquisition of Clinical Force

Adds Medidata CTMS® (Clinical Trial Management System) to solutions.

June 2011

Acquisition of Mytrus

Adds eConsent to the Medidata Platform.

April 2017

Acquisition of CHITA

Adds regulated content management and eTMF capabilities to the Medidata Platform.

June 2017

Acquisition of SHYFT Analytics

Powers customers’ digital transformation 
with AI and real-world analytics.

June 2018

Launches Medidata AI

Combines data, technology, and deep expertise to deliver actionable insights across the clinical development continuum—optimizing study execution and commercial success, and proving therapy value.

June 2019

Dassault Systèmes Acquires Medidata

Dassault Systèmes, the 3DEXPERIENCE company, acquires Medidata to accelerate the digital transformation of life sciences —pushing the boundaries of innovation and learning to build 
a more sustainable future for patients and society.

Read More

October 2019

Responding to COVID-19 with Data and Direction

Throughout 2020, Medidata publishes nine white papers analyzing COVID-19’s impact on drug and vaccine trials—assessing patient disruption and delivering data-driven guidance to help sponsors and CROs sustain and adapt studies worldwide.

March 2020

Launches myMedidata

Built for and with patients, myMedidata is an award-winning portal enabling participants to learn, enroll, and engage in trials from any device—powering scalable, flexible, decentralized, and hybrid study models.

April 2020

Powers Moderna’s COVID-19 Vaccine Trials

Medidata’s cloud platform enables the rapid advancement of Moderna’s mRNA-1273 program, supporting its 30,000-participant Phase 3 study with the scale, speed, and resilience required during the global pandemic.

Press Release

July 2020

Medidata Synthetic Control Arm® Supported by the FDA

In a regulatory first, the FDA permits Medicenna to use 
a hybrid external control arm in a Phase 3 registrational trial—building on a Phase 2 study in recurrent glioblastoma strengthened by Medidata’s Synthetic Control Arm®.

Press Release

October 2020

Launches 
myMedidata Registries

Expanding our patient portal to engage participants before enrollment and long after trial completion supports long-term follow-up and safety surveillance.

Press Release

June 2021

Introduces the First Unified Platform for DCTs

The industry’s first end-to-end, secure platform for decentralized clinical trials enables sponsors and CROs to manage drug, vaccine, and device studies seamlessly across the development continuum.

Press Release

June 2021

Launches Sensor Cloud and the Sensor Cloud Network

Delivering advanced data models and proprietary algorithms that rapidly ingest, normalize, and analyze patient-generated data accelerates decisions and timelines. The Sensor Cloud Network unites CROs, device makers, sponsors, analytics firms, and academia in the industry’s first cross-sector collaboration.

Read More

October 2021

Rave Imaging Surpasses 1,000 Studies

Exceeding 1,000 supported trials, Rave Imaging processes more than 100 million images annually—scaling secure, cloud-based imaging management 
for global clinical research.

October 2021

Remembering Glen de Vries

Glen set the highest standard for Medidata and championed our commitment to always innovate to solve our industry’s most complex problems. 
We will further Glen’s mission by continuing to push the boundaries of what’s possible.

November 2021

Opens up Patient Insights Program

Enabling sponsors, CROs, and sites to embed patient perspectives directly into software design and improve the clinical research experience.

Read More

February 2022

30,000 Trials, 9 Million Participants

The first life sciences technology company to surpass 30,000 trials and 9 million study volunteers.

Press Release

March 2023

Showcases Clinical Data Studio and Health Record Connect

New experiences for enhancing and streamlining clinical data workflows.

November 2023

Anthony Costello Named CEO

Anthony Costello has advanced the use of technology in clinical trials for nearly 30 years. Across numerous leadership roles from entrepreneur to corporate c-suite, Anthony has transformed the patient, site, and sponsor experience, while accelerating the delivery of life-changing treatments.

March 2024

Recognized for Site Innovation

Medidata was presented with the inaugural Site Innovation Award for its groundbreaking work in improving efficiency in clinical trials by the Summit for Clinical Ops Executives (SCOPE).

Press Release

March 2024

Global Rollout of Clinical Data Studio

Delivers a unified research experience with greater data quality control.

Clinical Data Studio

March 2024

Launches
Patient Payments

A new solution for streamlining trial-related stipends and reimbursements for patients participating in clinical research.

Patient Payments

September 2024

Introduces Rave Lite

An extension of its gold-standard clinical research software, Rave EDC, and designed explicitly for Phase I and IV studies.

Rave Lite

October 2024

Enters CNS Space with Cogstate Partnership

A partnership with neuroscience solutions leader Cogstate reshapes clinical trials and outcomes measurement for central nervous system (CNS) diseases across neurodegenerative, psychiatric, motor, and rare neurodevelopmental disorders.

Press Release

October 2024

35,000 Trials,
10 Million Participants

Surpasses 35,000 trials and 10 million study volunteers worldwide.

November 2024

Integrates UK Health Costing Data

First to integrate UK-mandated Health Costing Data into its financial management portfolio.

February 2025

Another Milestone

Surpasses 36,000 Clinical Trials and 11 Million Participants

March 2025

Launches Site Insights Program

Elevating the Site Voice and strengthening site partnership and performance in clinical trials.

MARCH 2025

Launches Protocol Optimization

Unveils Protocol Optimization at ASCO, advancing data-driven study design and execution.

May2025

Trust and Transparency

Your innovations must be as trustworthy as they are transformative. That’s why every AI capability is built on secure data practices, explainable models, and accountable governance. 



Ethical, human-centered intelligence helps you move faster—
while protecting patients, data, and regulatory integrity.

Learn More

Values and Corporate Social Responsibility

Our industry-leading CSR program helps you partner with a company built for long-term, responsible growth.

Aligned with our parent company’s goal of carbon neutrality by 2040, we invest in sustainable innovation, build strategic partnerships, and continuously strengthen employee expertise—so your trials advance with resilience, accountability, and measurable impact.

IMPACT

Social Innovation Lab

SIL is a skills-based volunteering program that pairs employees with non-profit partners—working on priority projects that NPOs don’t have the resources to drive.

Supporting STEM Innovation

Medidata can provide funds for STEM education, mentor students, and offer insight into the exciting world of life sciences. Our partners include Girls Who Code, All Star Code, and Career Spring.

Gift Matching

Causes that matter to our employees matter to us. We matched approximately $350,000 of employee donations to causes they are passionate about in their communities.

Sustainability

We measure our progress toward carbon neutrality by 2040 by reporting under Dassault Systèmes as a subsidiary for global environmental, social, and governance (ESG) management.

Awards and Recognition

2024

IDC MarketScape Worldwide Life Science R&D DCT Technology Solutions and Consulting Services

2025

Medidata x Cogstate Partnership
Best Clinical Trial Technology Solution Provider

2023 & 2024

Everest Group Life Sciences Clinical Data and Analytics (D&A) Platforms

2022 & 2023

Everest Group Decentralized Clinical Trial Platforms

View All Awards

Our CSR Programs Have Supported

students in STEM
0 K+
patients with access to care
0 K
volunteer hours
0 K

PROJECT PARTNERS

Remembering Glen de Vries

Entrepreneur, philanthropist, aviation and space enthusiast, died on November 11, 2021.

We’re proud to honor the legacy of our dear friend and co-founder, Glen de Vries. His curiosity, creativity, and compassion continue to inspire us as we all push forward on his quest to bring help and hope to patients around the globe. 

Glen set the highest standard for Medidata and championed our commitment to always innovating to solve our industry’s most complex problems. We will further Glen’s mission by continuing to push the boundaries of what’s possible.